# Ibd CAncer and seRious Infections in France (I-CARE 2)

> **NCT06089590** · — · RECRUITING · sponsor: **Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives** · enrollment: 6000 (estimated)

## Conditions studied

- IBD
- Ulcerative Colitis
- Crohn Disease

## Interventions

- **OTHER:** Non-interventional

## Key facts

- **NCT ID:** NCT06089590
- **Lead sponsor:** Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-25
- **Primary completion:** 2031-03-01
- **Final completion:** 2031-03-01
- **Target enrollment:** 6000 (ESTIMATED)
- **Last updated:** 2025-03-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06089590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06089590, "Ibd CAncer and seRious Infections in France (I-CARE 2)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06089590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*